Market Overview
The global Helicobacter Pylori Self-Test Kit market was valued at USD 2666 million in 2024 and is projected to reach USD 4186 million by 2031, exhibiting a CAGR of 6.8% during the forecast period. The market growth is primarily driven by increasing awareness of gastrointestinal health, rising demand for home-based diagnostic solutions, and growing prevalence of H. pylori infections globally. According to the World Health Organization, approximately 50% of the global population is infected with H. pylori, with higher prevalence in developing countries.
The Asia-Pacific region holds the largest market share (38.2%) due to high disease burden and increasing healthcare expenditure.
USD 2666 million in 2024
USD 4186 million by 2031
of 6.8%
Rapid Test Kits
PCR-Based Test Kits
Rapid Test Kits continue to dominate the market due to their ease of use, quick results, and cost-effectiveness for home testing. The growing preference for non-invasive diagnostic methods has significantly accelerated the adoption of rapid test formats across both developed and emerging markets.
By Application
Home Use
Clinic Use
Research Institutions
Others
Home Use represents the fastest growing segment as consumers increasingly seek convenient and private health monitoring solutions. The rise of direct-to-consumer healthcare products has empowered individuals to take proactive control of their gastrointestinal health, with home testing offering discreet, accessible, and immediate results without requiring clinical visits.
https://www.24lifesciences.com
Our Key Players
Abbott Laboratories (USA)
Roche Diagnostics (Switzerland)
Quidel Corporation (USA)
Sekisui Diagnostics (Japan)
